<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9719">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00726063</url>
  </required_header>
  <id_info>
    <org_study_id>2613</org_study_id>
    <nct_id>NCT00726063</nct_id>
  </id_info>
  <brief_title>A Prospective Study Evaluating the Performance of Nanotite Osseotite Implants When Placed by Graduate Student Programs</brief_title>
  <acronym>CollegeBowl</acronym>
  <official_title>A Prospective Randomized-controlled Evaluation of Nanotite and Osseotite Surfaced Implant Performance in Graduate Student Programs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biomet, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biomet, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the contributions of the Nanotite implant design when used by
      graduate students in their first year of placing implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This multicenter, prospective, randomized-controlled study will compare the performance of
      the Nanotite vs. the standard Ossotite implants when placed by graduate students with little
      or no prior experience. Enrolled patients will have the study site(s) randomized to either a
      Nanotite (test) or an Osseotite (control) implant. The manner of treatment observed at the
      participating center will be followed for this study.

      Study Hypothesis: The performance of the Nanotite implant in this study will be no different
      than or superior to that of the Osseotite implant placed during the early period of graduate
      student training.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Integration Success of the Implant</measure>
    <time_frame>1 year</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Prosthesis Survival and Procedural Success</measure>
    <time_frame>3 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">241</enrollment>
  <condition>Tooth Disease</condition>
  <condition>Partial Edentulism</condition>
  <arm_group>
    <arm_group_label>Nanotite implant</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nanotite dental implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osseotite implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Osseotite dental implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nanotite dental implant</intervention_name>
    <description>Nanotite root form titanium dental implant</description>
    <arm_group_label>Nanotite implant</arm_group_label>
    <other_name>Nanotite endosseous dental implant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osseotite dental implant</intervention_name>
    <description>Osseotite Root form titanium dental implant</description>
    <arm_group_label>Osseotite implant</arm_group_label>
    <other_name>Osseotite endosseous dental implant</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex and of any race, 18 years of age or older

          -  patients for whom a decision has already been made to use dental implants for
             treating edentulism in the mandible or maxilla

        Exclusion Criteria:

          -  patients who are known to be pregnant
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael S Reddy, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <lastchanged_date>January 13, 2015</lastchanged_date>
  <firstreceived_date>July 29, 2008</firstreceived_date>
  <firstreceived_results_date>November 19, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dental implants</keyword>
  <keyword>Nanotite implant</keyword>
  <keyword>Osseotite implants</keyword>
  <keyword>multicenter</keyword>
  <keyword>randomized</keyword>
  <keyword>clinical study</keyword>
  <keyword>partial edentulism</keyword>
  <keyword>prosthesis</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Up to 165 patients are expected to be enrolled across all centers, with enrollment efforts beginning in August 2008. Enrollment period remained opent until December 2010.</recruitment_details>
      <pre_assignment_details>Pre-treatment included a screening visit (enroll those meeting all protocol inclusion criteria), signing informed consent, and pre-surgical data collection. Patients returned for implant placement surgery, followed by restorative activities.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nanotite Implant</title>
          <description>Nanotite dental implant
Nanotite dental implant : Nanotite root form titanium dental implant</description>
        </group>
        <group group_id="P2">
          <title>Osseotite Implant</title>
          <description>Osseotite dental implant
Osseotite dental implant : Osseotite Root form titanium dental implant</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="122">Number of implants= 239</participants>
                <participants group_id="P2" count="119">Number of implants= 246</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="113">Number of implants =230</participants>
                <participants group_id="P2" count="112">Number of implants = 239</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="9"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Nanotite implants = 239 Osseotite implants = 246</population>
      <group_list>
        <group group_id="B1">
          <title>Nanotite Implant</title>
          <description>Nanotite dental implant
Nanotite dental implant : Nanotite root form titanium dental implant</description>
        </group>
        <group group_id="B2">
          <title>Osseotite Implant</title>
          <description>Osseotite dental implant
Osseotite dental implant : Osseotite Root form titanium dental implant</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="122"/>
                <measurement group_id="B2" value="119"/>
                <measurement group_id="B3" value="241"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>Overall number of Nanotite implants = 239 Overall number of Osseotite implants = 246 Nanotite implants in &lt;18 yrs = 1 Nanotite implants in 18-65 = 163 Nanotite implants in &gt;65 = 75 Osseotite implants in &lt;18 yrs = 0 Osseotite implants in 18-65 = 173 Osseotite implants in &gt;65 = 73</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="61"/>
                <measurement group_id="B2" value="63"/>
                <measurement group_id="B3" value="124"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="60"/>
                <measurement group_id="B2" value="56"/>
                <measurement group_id="B3" value="116"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Overall number baseline implants Nanotite= 239 Overall number baseline implants Osseotite = 246 Nanotite implants in Females = 116 Nanotite implants in Males = 123 Osseotite implants in Females = 120 Osseotite implants in Males = 126</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="61"/>
                <measurement group_id="B2" value="64"/>
                <measurement group_id="B3" value="125"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="61"/>
                <measurement group_id="B2" value="55"/>
                <measurement group_id="B3" value="116"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Integration Success of the Implant</title>
        <time_frame>1 year</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Number of implants surviving (lack of mobility) at the end of the study (time of analysis)</population>
        <group_list>
          <group group_id="O1">
            <title>Nanotite Implant</title>
            <description>Nanotite dental implant
Nanotite dental implant : Nanotite root form titanium dental implant</description>
          </group>
          <group group_id="O2">
            <title>Osseotite Implant</title>
            <description>Osseotite dental implant
Osseotite dental implant : Osseotite Root form titanium dental implant</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="122"/>
                  <measurement group_id="O2" value="119"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Number of Implants analyzed</title>
            <units>Implants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="239"/>
                  <measurement group_id="O2" value="246"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Integration Success of the Implant</title>
            <units>implants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="230"/>
                  <measurement group_id="O2" value="239"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Prosthesis Survival and Procedural Success</title>
        <time_frame>3 years</time_frame>
        <safety_issue>No</safety_issue>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events are collected and reported throughout the duration of the study, an average of 2 years.</time_frame>
      <desc>Adverse event data is collected by patient questioning,visual examination, and radiologic assessment of patient's treatment area each study event visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Nanotite Implant</title>
          <description>Nanotite dental implant
Nanotite dental implant : Nanotite root form titanium dental implant</description>
        </group>
        <group group_id="E2">
          <title>Osseotite Implant</title>
          <description>Osseotite dental implant
Osseotite dental implant : Osseotite Root form titanium dental implant</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA (12.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="122"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Loss of integration of implant</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="122"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="119"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Manager</name_or_title>
      <organization>Biomet 3i LLC</organization>
      <phone>5617766722</phone>
      <email>cristina.matthews@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
